Methods for preventing graft ischemia reperfusion injury during ex vivo machine perfusion preservation
AssigneeUniversity of Massachusetts
InventorsPaulo Martins, Xiaofei E., Timothy Kowalik
Life of this patent
Estimating the term…
Abstract
The invention provides methods for treating ischemia (such as ischemia repertusion injury (IRI)) in tissue (such as transplant donor tissue), comprising contacting the tissue during ex vivo perfusion with a therapeutically effective amount of RNAi (such as siRNA) that specifically hinds to at least a portion of a gene (such as p53) that mediates ischemic injury in the tissue. The invention's methods additionally decrease the risk of tissue rejection and/or or induce immunological tolerance to transplanted tissue.
Claims26
A method for treating ischemia in a target tissue, comprising contacting the tissue, during ex vivo perfusion of the tissue, with a therapeutically effective amount of RNAi sequence that specifically binds to at least a portion of a gene that mediates ischemic injury in the tissue, thereby producing a treated tissue.
A method for reducing injury in a target tissue, comprising perfusing the tissue in the presence of siRNA that reduces gene expression of a gene hat causes ischemic injury in the tissue, thereby reducing;
- injury and producing a treated tissue.
Dependencies are inferred from the claim text.